Earningsreport

Q2/2024 6/30/2024 EPS -0.370 ZacksConsensus -0.350 ActVsEst (0.020) - Miss

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation